Biotech · Private company
QOL Medical, LLC
Track this companyFree. Adds QOL Medical, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Sacrosidase Oral SolutionPhase 2 · Fructan IntoleranceClinicalTrials.gov · fetched Nov 12, 2026
- Sucraid (sacrosidase) Oral Solution 8500 IU/mLCongenital Sucrase-Isomaltase DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Sucrose Hydrogen Methane Breath TestCongenital Sucrase-Isomaltase DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Effects of Sacrosidase and Placebo in Subjects With Fructan IntolerancePHASE2 · COMPLETED · started Jun 5, 2023ClinicalTrials.gov NCT05703009 · fetched Nov 12, 2026
- 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase LevelsPHASE4 · TERMINATED · started Aug 1, 2022ClinicalTrials.gov NCT05480761 · fetched Nov 12, 2026
- Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal FailurePHASE2 · TERMINATED · started Jan 31, 2022ClinicalTrials.gov NCT04604275 · fetched Nov 12, 2026
- Adult Pilot Study for Reference Ranges and Optimal Cut-offs for the Sucrose Challenge Test and Sucrose Breath TestCOMPLETED · started Aug 30, 2021ClinicalTrials.gov NCT05045495 · fetched Nov 12, 2026